BEAMing Sysmex Gets Japanese Manufacturing, Marketing Approval for Colorectal Cancer Screening Assay The firm believes that physicians can use information from the cell-free DNA analyzed by the assay to determine whether to use anti-EGFR drugs during treatment. Prospective Study Supports Liquid Biopsy Monitoring of Colorectal Cancer Drug Response Premium The results confirmed that circulating mutations can be reliably detected and changed during treatment, and showed that they could be a valuable prognostic biomarker. Novartis PI3K Inhibitor Effective in Breast Cancer Subset; Psych Toxicities Dampen Enthusiasm Premium Amid concerns about buparlisib's toxicity profile, a study suggests there might be a benefit for a subpopulation of patients with a more targeted PI3K inhibitor. Expansion of Liquid Biopsy Test Sites Planned by Merck KGaA, Sysmex Premium The firms will set up sites for OncoBEAM RAS CRC in Argentina, Brazil, Malaysia, Indonesia, Vietnam, and India, and present data at major medical conferences. Merck KGaA, Sysmex Inostics Garner CE Mark for Liquid Biopsy CRC Test The firms now plan to market the test in Europe, Asia, and Australia as a tool oncologists can use to identify best responders to EGFR inhibitors. Feb 16, 2016 Eisai, Sysmex to Develop Dx, CDx for Dementia Jul 14, 2015 Liquid Biopsies Uncover Mutations That Develop During Tumor Progression Feb 24, 2015 Spanish Cancer Institute Using Sysmex Inostics, Merck Serono Blood Dx to Study mCRC Personalized Rx Premium Feb 18, 2015 Clovis Evaluating Sysmex Inostics Blood Assay to ID EGFR Mutations in ctDNA of NSCLC Patients Premium Jun 5, 2014 Sysmex Inostics, Merck Aim for 2015 CE Mark for ctDNA Kit for Metastatic Colorectal Cancer Premium Feb 21, 2014 Roche Licenses Emulsion PCR Patents to Sysmex Inostics Feb 19, 2014 Cross-Cancer Analysis Clarifies Characteristics of Circulating Tumor DNA Oct 10, 2013 Bayer, Sysmex Inostics to Develop BEAMing CDx Tests for New Cancer Therapies Premium Oct 9, 2013 Sysmex Inostics, Bayer to Develop Companion Diagnostics for Cancer Therapies Sep 26, 2013 Japan's Sysmex to Integrate Tech from Inostics, Partec for Personalized Medicine, CDx Premium Aug 1, 2013 MGH Team Uses BEAMing/Digital PCR Method to Track Mutations in Glioblastoma Extracellular Vesicles Premium May 30, 2013 Inostics' Lab Gains CLIA Licensure Apr 11, 2013 Dx Focus: BD Max Cdiff; Hologic Aptima HPV; Inostics BEAMing Tech; Veredus Labs VereFlu Test Premium Jun 28, 2012 Studies Show Promise of Inostics' BEAMing Tech to Detect Drug Resistance Markers in Cancer Patients Premium Aug 18, 2011 As it Readies US Lab, Germany's Inostics Moving Beyond Service Model with Digital PCR Tech Premium Jul 15, 2010 New Players Seek Foothold in Digital PCR Market amid 'Thorny' IP Landscape Premium Breaking News Roche Receives EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test Decode Study Identifies Proteomic Predictors of All-Cause Mortality In Brief This Week: Natera, Bruker, Bayer, and More New Products Posted to GenomeWeb: Labcorp, Omniseq, Dovetail Genomics, DNA Script, More People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test The Scan Billions for Antivirals The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports. NFT of the Web Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports. 23andMe on the Nasdaq 23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported. Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.